ArticleFrontiers in pharmacology2015

Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells.

Daniele Tibullo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.